Skip to NavigationSkip to content

News

0
The findings supported the non-inferiority of Biktarvy to a standard regimen of two nucleoside reverse transcriptase inhibitors (NRTIs) and a third...
0
The EMA has recommended marketing authorisation for ten medicines and has also suggested ten label extensions.
0
The University of Oxford and AstraZeneca say they will continue their coronavirus vaccine clinical trials after a volunteer had died while on the...
0
As part of the deal, the company will admit that it misled the Drug Enforcement Agency (DEA) through falsifying its drug diversion programme by...

Features

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive...